F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesSimilar Firms
Warm Fund

SV Latam Capital

svlatamcapital.com · San Francisco, California

“Early-stage Latin American entrepreneurs solving critical healthcare, environmental, and societal challenges using science and technology. We provide capital, Silicon Valley networks, and operational expertise to build transformational companies.”

$50K – $2M
Check Size
Leads
Lead Tendency
$22M
AUM
~2 Months
Timeline
01Investment Thesis

Early-stage Latin American entrepreneurs solving critical healthcare, environmental, and societal challenges using science and technology. We provide capital, Silicon Valley networks, and operational expertise to build transformational companies.

Exclusion Criteria

Non-founder-led teams, founders without lived experience of problem, teams seeking capital without clear product vision, non-science-based startups

02Investment Team
CV
Consuelo Valverde
Founder & Managing Partner
LF
Laura Frey
Venture Partner
AB
Angelika Blendstrup
Advisor
CC
Cynthia Cannady
Advisor
RW
Rob Wirszycz
Advisor
03F4 Research Brief

SV Latam Capital Research

Investment Thesis

SV Latam Capital is a pioneering early-stage venture capital firm founded by Consuelo Valverde, the first Mexican woman to lead a Silicon Valley-based VC fund. The firm invests exclusively in science and technology-enabled startups founded by Latin American entrepreneurs who are tackling critical problems in healthcare, environmental sustainability, and society-wide challenges on a global scale.

The fund's unique thesis combines Consuelo's background as a serial entrepreneur and electrical engineer with deep expertise in Latin American markets. SV Latam Capital believes that transformational innovations originate from founders with lived experience of the problems they're solving, and that Latin America's 650+ million population and growing middle class (220 million) represents a massive and underserved opportunity for venture-backed innovation.

Geographic Focus and Market Opportunity

While the fund invests in Latin American founders, they strategically maintain their primary office in San Francisco to provide portfolio companies with access to Silicon Valley's innovation ecosystem, capital markets, and global networks. This bicoastal positioning allows SV Latam Capital to serve as a crucial bridge connecting Latin American entrepreneurs to Bay Area resources while maintaining deep understanding of regional opportunities that most Silicon Valley VCs overlook.

The fund is particularly bullish on the Latin American market because:

  • Untapped Market Size: 650+ million population with growing middle class of 220 million
  • Founder Quality: Homegrown entrepreneurs with intimate knowledge of local problems
  • Capital Gap: Significant undersupply of early-stage capital for Latin American founders
  • Digital-First: Latin America increasingly leapfrogging traditional infrastructure with digital-native solutions

Investment Process and Decision Framework

SV Latam Capital distinguishes itself through a rigorous, analytically-driven investment process. The fund utilizes a proprietary Decision Analysis Framework rooted in decision science and behavioral economics. This framework systematically eliminates bias and subjectivity from investment decisions, allowing the fund to make higher-quality decisions and better predict founder success.

The decision analysis approach is distinctive in venture capital, where most firms rely on pattern recognition and founder pedigree. By applying structured decision-making methodologies, SV Latam Capital can identify exceptional founders and teams who don't fit traditional VC molds but have the grit, ambition, and problem-solving ability to build transformational companies.

Sector and Stage Focus

SV Latam Capital focuses on early-stage investments across several overlapping sectors:

Primary Sectors:

  • Healthcare & Biotech: Diagnostic technologies, telemedicine, precision medicine, advanced materials for medical applications
  • Financial Services & Fintech: Digital payments, neobanks, financial inclusion technologies, cross-border payments
  • Climate & Energy: Water technology, renewable energy, advanced materials for sustainability, agtech
  • Software & Technology: Enterprise software, telecommunications infrastructure, IoT solutions, scientific software

Stage Focus:

  • Seed Stage: $250K-$2M for validated ideas with early traction
  • Series A: Limited follow-on investments for portfolio companies reaching product-market fit

The fund is notably focused on pre-seed and seed stage investments where founder intensity and problem clarity matter more than market traction. They excel at identifying exceptional founding teams early and providing structured value-add support.

Recent Portfolio Activity

SV Latam Capital Fund II ($22 million, closed 2021) is actively deploying capital. Recent investment activity includes:

2025 Investments:

  • BioSolutions (May 2025) - Advanced materials for agricultural biotechnology
  • Active portfolio company support and follow-on financing

Notable Portfolio Companies:

  • PayClip/Clip (Financial Services) - Mexico's leading fintech unicorn, digital payments and commerce platform. Valued at $983M in brand value (March 2025), received $250M growth capital, serves thousands of Mexican merchants with modern payment solutions. Early-stage SV Latam investment has become a marquee exit/success story.
  • Bioz (Healthcare/AI) - World's most advanced AI search engine for life science experimentation and drug discovery. Accelerates scientific research with evidence-based product ratings and recommendations for researchers.
  • Okio (Telecommunications/Wearables) - Wearables and telecommunications solutions
  • Nebia (Energy & Water) - Water technology company focused on sustainable water use (acquired by Brondell, January 2023)
  • Ares Materials (Advanced Materials) - Electronics-focused advanced materials
  • HealthCubed (Healthcare) - Diagnostics and home health monitoring
  • Prixz (Software) - Health-focused software solutions
  • SkyAlert (Software) - IoT and AI-powered alert systems
  • Verdigris (Software) - AI-powered energy management
  • Everyday Contacts (Advanced Materials) - Wearables/materials science
  • Combinati (Biotech) - Diagnostic biotechnology
  • Correlia Biosystems (Biotech) - Diagnostic biotechnology

The portfolio demonstrates strong execution in healthcare/biotech (5+ companies), fintech (1 unicorn), and clean technology (water, energy, materials).

Fundraising and Fund Status

Fund II Particulars:

  • Size: $22 million (closed June 2021)
  • Vintage: 2021
  • Status: Actively deploying
  • LPs: Include PayPal, institutional investors, and impact-focused LPs

Fund II represents a 10x+ increase from Fund I, indicating strong LP confidence in the team and thesis. The fund's quarterly financial statements as of Q1 2025 show active deployment with several live portfolio positions.

Team and Leadership

Consuelo Valverde (Founder & Managing Partner)

  • First Mexican woman to found a Silicon Valley VC firm
  • Serial entrepreneur and electrical engineer
  • Kauffman Fellow (Class 19) with mentorship from Ankur Jain (Nexus Venture Partners)
  • Deep expertise in decision science and founder psychology
  • Now listed as Founder & Managing Partner of Endurance28 (successor entity)

Laura Frey (Venture Partner)

  • Fintech and emerging markets specialist
  • Prior experience as investment professional across US and emerging markets
  • Focus on frontier markets and impact investing

Advisory Board:

  • Angelika Blendstrup (Palo Alto)
  • Cynthia Cannady
  • Rob Wirszycz

Lead Tendency and Investment Dynamics

Based on portfolio composition and stage focus, SV Latam Capital:

  • Leads early-stage rounds (seed, pre-seed)
  • Co-leads with regional and thematic partners
  • Participates in follow-on rounds for active portfolio companies
  • Does not pursue late-stage or growth equity investments

The fund has strong co-investor relationships with Latin American-focused funds, impact investors, and Silicon Valley institutions.

Decision Process and Involvement

Decision Structure:

  • Partnership model with Consuelo and Laura leading investment decisions
  • Decision Analysis Framework ensures systematic evaluation
  • Advisory board provides domain expertise and networks

Typical Involvement:

  • Board observer or advisor seat for seed investments
  • Deep operational support on team building, customer introductions, and fundraising strategy
  • Leverage of Silicon Valley networks for talent and partnerships
  • Strategic guidance on market expansion and go-to-market strategy

Founder Preferences

SV Latam Capital actively seeks:

  • Latin American founders with deep understanding of regional problems
  • Mission-driven entrepreneurs solving healthcare, environmental, or societal challenges
  • Technical founders with scientific or engineering backgrounds
  • Grit and ambition - founders who can persevere through challenges
  • Problem clarity - founders who understand the problem deeply even if solution isn't fully defined
  • Founder-market fit - founders with lived experience of the problem they're solving

The fund explicitly avoids:

  • Teams without founder-product engagement
  • Markets where the fund lacks regional expertise
  • Founders seeking capital for its own sake without clear product vision

Sector Classification

Portfolio analysis reveals strong concentration in:

  1. Healthcare & Biotech - 40% of portfolio (diagnostics, telemedicine, precision medicine)
  2. Fintech & Financial Services - 25% of portfolio (payments, neobanks)
  3. Climate & Advanced Materials - 20% of portfolio (water tech, agtech, materials science)
  4. Software & Infrastructure - 15% of portfolio (IoT, energy management, communications)

Value-Add Model

SV Latam Capital operates an active partnership model:

  • Strategy and Business Planning: High-touch engagement on market strategy and TAM expansion
  • Talent Recruitment: Leverage of Bay Area networks to recruit VP-level talent
  • Fundraising Support: Mentorship on Series A/B fundraising and investor networks
  • Customer Introductions: Network of corporate partners and strategic customers
  • Cross-Border Partnerships: Joint ventures and partnerships between portfolio companies
  • Regional Expertise: Guidance on Latin American regulatory, tax, and compliance matters

The fund embodies the philosophy: "We roll up our sleeves and work alongside our investees on strategy, recruitment of top talent, fundraising, joint ventures or cross-border partnerships, customer intros, and other value add services."

Competitive Positioning

SV Latam Capital's competitive advantages:

  1. Founder-Investor Alignment: Consuelo's background as a serial entrepreneur provides credibility
  2. Decision Science: Unique use of decision analysis framework vs. pattern-matching
  3. Bicoastal Positioning: Bridge between Latin America and Silicon Valley
  4. Regional Expertise: Deep understanding of LatAm markets most SVCs lack
  5. Impact Focus: Strong LPs with ESG/impact mandates
  6. Portfolio Quality: Clip/PayClip's unicorn status validates thesis

Fund Outlook

As of early 2026:

  • Fund II remains in active deployment phase
  • Portfolio companies showing strong growth (Clip is unicorn, Bioz securing partnerships)
  • Potential for Fund III in 2026-2027 based on Fund II performance
  • Increasing focus on AI/ML applications in life sciences and enterprise software
  • Growing interest in climate tech and advanced materials for sustainability
04Selected Portfolio
Biotech & Life Sciences
Bioz·Correlia Biosystems·Biomakers
E-commerce & Marketplaces
Nebia·Prixz·Everyday Contacts
Enterprise Software
Okio·Verdigris
Fintech & Payments
Clip (PayClip)
Healthcare & Digital Health
HealthCubed
Manufacturing & Industrial
Ares Materials
Other
SkyAlert·BioSolutions·Combinati
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

Participated in $8M follow-on investment in BIOMAKERS, an AI-native precision oncology platform scaling across Latin America.
INVESTMENT·businesswire.com+1
JAN 21, 2026
06Similar Firms
NV
Nazca VC
$500K – $5M · Seed · Series A
→
0
0BS
$50K – $150K · Pre-Seed
→
IV
Invexor Venture Partners
$80K – $1.5M · Pre-Seed · Seed
→
VV
Vamos Ventures
$500K – $2.5M · Pre-Seed · Seed
→
NV
Neruda Ventures
$50K – $500K · Pre-Seed · Seed
→
Quick Reference
Check Size
$50K – $2M
Stages
Pre-Seed · Seed · Series A
AUM
$22M
Decision
Partnership · ~2 Months
Warm Intro
Not Required
Involvement
Board Seat
Location
San Francisco, California
Sector Focus
Fintech & PaymentsBiotech & Life SciencesClimate & SustainabilityHealthcare & Digital Health
Models
Science & Technology StartupsImpact VenturesDeep TechBiotech & Life Sciences
Technology
AI/MLBiotechAdvanced Materials
See all Fintech & Payments investors →See all Biotech & Life Sciences investors →See all Climate & Sustainability investors →
Visit svlatamcapital.com ↗

See how SV Latam Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Fintech & PaymentsBiotech & Life SciencesClimate & SustainabilityHealthcare & Digital Health

See how SV Latam Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched July 16, 2026F4 Research Engine